These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


800 related items for PubMed ID: 8633584

  • 1. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S, Berstad A, Bang CJ, Nysaeter G, Hatlebakk JG, Olafsson S, Nesje LB, Hausken T, Berstad K, Hundal O.
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 3. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
    Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, Hausken T, Weberg R, Nesje LB, Hjartholm AS.
    Hepatogastroenterology; 1995 Dec; 42(5):655-9. PubMed ID: 8751230
    [Abstract] [Full Text] [Related]

  • 4. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker JH.
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [Abstract] [Full Text] [Related]

  • 5. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD, Wurzer H, Marcelino M, Jahnsen J, Lotay N, Roberts PM.
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [Abstract] [Full Text] [Related]

  • 6. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolås P, Aubert E, Henriksen M, Efskind PS, Nicolaysen K, Søberg T, Odegaard A, Berge T.
    Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
    [Abstract] [Full Text] [Related]

  • 7. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 8. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP, Fuentes J, Carpio D, Tito L, Guardiola J, Tomas A, Olivares D, Calvet X.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1249-53. PubMed ID: 15882246
    [Abstract] [Full Text] [Related]

  • 9. Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway.
    Berstad A, Olafsson S, Tefera S, Berstad K, Hundal O, Bergseth M, Wilhelmsen I.
    J Physiol Pharmacol; 1996 Mar 15; 47(1):31-49. PubMed ID: 8777305
    [Abstract] [Full Text] [Related]

  • 10. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA, Haeck PW, Otten MH, Mulder CJ.
    Am J Gastroenterol; 1998 Jul 15; 93(7):1101-7. PubMed ID: 9672338
    [Abstract] [Full Text] [Related]

  • 11. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar 15; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 12. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2001 May 15; 96(5):1390-5. PubMed ID: 11374672
    [Abstract] [Full Text] [Related]

  • 13. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr 15; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 14. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H, Bardhan KD, Marcelino M, Jahnsen J, Allmaier M.
    Hepatogastroenterology; 2001 Apr 15; 48(42):1641-7. PubMed ID: 11813591
    [Abstract] [Full Text] [Related]

  • 15. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
    Lerang F, Moum B, Ragnhildstveit E, Sandvei PK, Tolås P, Whist JE, Henriksen M, Haug JB, Berge T.
    Am J Gastroenterol; 1998 Feb 15; 93(2):212-6. PubMed ID: 9468244
    [Abstract] [Full Text] [Related]

  • 16. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    Smoot DT, Hinds T, Ashktorab H, Jagtap J, Kim KS, Scott VF.
    Am J Gastroenterol; 1999 Apr 28; 94(4):955-8. PubMed ID: 10201463
    [Abstract] [Full Text] [Related]

  • 18. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H, Sánchez Anguiano LF, Quiñones E.
    Rev Gastroenterol Mex; 1998 Apr 28; 63(1):21-7. PubMed ID: 10068745
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
    Massarrat S, Ihm P, Koch HK.
    Arzneimittelforschung; 1998 Jun 28; 48(6):686-90. PubMed ID: 9689428
    [Abstract] [Full Text] [Related]

  • 20. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    Altintaş E, Ulu O, Sezgin O, Aydin O, Camdeviren H.
    Turk J Gastroenterol; 2004 Jun 28; 15(2):90-3. PubMed ID: 15334317
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.